Investors looking for solid income stocks to boost their passive income can find some attractive opportunities in 2025. The past few years have seen high inflation and interest rates put pressure on the financial results and share prices of top consumer brands. This has driven the dividend yield up to attractive levels for several top companies.To give you some ideas, three Fool.com contributors believe Target (TGT -0.22%), Starbucks (SBUX 0.60%), and Philip Morris (PM -0.28%) are solid buys today. Here's w ...

British American Tobacco p.l.c. (NYSE: BTI ) is arguably the “second-best” tobacco company in the world. Their brands are well known and have top market shares, but they are not Marlboro. Their journey into next generation products (heat-not-burn, vapes andStriving to compound knowledge. Long-time fan of Warren and Charlie. Always invert. "To finish first, you must first finish". Investing own and family funds for +20 years. Senior finance roles at public and private corporations for most of that time.Analy ...

Tobacco stock Altria Group, Inc. (NYSE: MO ) has had an underwhelming 2025 so far at the stock markets compared with its peers. Even with its ~11% increase YTD, which is considerably ahead of the consumer staples sector, as seen from the 3.2% rise inManika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. Her ...

Altria (MO -1.28%) is an iconic consumer staples maker that has shifted and changed over the years. Today it is largely a tobacco stock, though it has investments in a beverage maker. Philip Morris International (PM -1.89%) shares some of the storied history of Altria, but the smartest investors know that its business is better. How are Altria and Philip Morris related?Altria's most important cigarette brand is Marlboro. Marlboro has a huge 41% market share in the North American market. Add in the company's ...

State Authorizations Mean Even More Adult Smokers Will Be Able to Purchase VLN®, Partner VLN®, Smoker Friendly and Pinnacle Products MOCKSVILLE, N.C., July 17, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), today announced a significant increase in state authorizations for the sale of its growing portfolio of both proprietary and contract manufactured products. The increase in state authorizations enables new sales activity and new product launches for 22nd Century’s proprietary VLN® red ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Multiple Tobacco Brands Partnering with 22nd Century to Expand Availability and Awareness of VLN Based Reduced Nicotine Content Products Manufactured in the USA, VLN Products from 22nd Century Provide Clinically Proven Solution to Reduce the Rate and Harms of Smoking MOCKSVILLE, N.C., July 16, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction ...

行业动态 - 22nd Century Group与多家烟草品牌合作推广VLN低尼古丁含量产品 旨在扩大市场覆盖和消费者认知 [1] - 合作品牌包括Smoker Friendly VLN和Pinnacle VLN 反映行业加速适应FDA新规的趋势 [2] - FDA 2025年1月提案要求香烟尼古丁含量上限为0.7mg/g 22nd Century产品已达标(平均0.5mg/g) [3][5] 公司技术优势 - VLN香烟采用专利技术 尼古丁含量比传统香烟低95% 通过调节烟草植物生物合成实现 [1][8][9] - 产品基于27年研究 数十项同行评审研究证实可降低吸烟率和健康危害 [1][5] - 公司拥有美国及关键国际市场唯一低尼古丁可燃香烟专利组合 [9] 市场影响 - FDA预测新规实施后 到2100年美国将减少4800万青少年吸烟者 [4] - VLN是目前唯一获FDA授权符合新规的可燃香烟产品 提供尼古丁摄入控制选择 [3] - 公司计划在获州批准后50个州全面铺货 消除政策落地的商业障碍 [3] 监管进展 - 2025年1月提案设定两年过渡期 22nd Century正参与规则意见征询 [5][6] - 2018年规则制定已采纳公司建议 包括0.7mg/g标准及供应可行性数据 [5] - 前FDA局长称该政策可能成为"一代人最具影响力的健康决策" [6] 产品特性 - VLN保持传统香烟口感 但尼古丁含量降低95% 帮助消费者逐步戒断 [7][8] - 产品采用专有低尼古丁烟草叶 已具备满足市场需求的量产能力 [5][9] - 区别于尼古丁替代产品 VLN提供完全避免成瘾性摄入的选择 [8]

Vaughan, Ontario--(Newsfile Corp. - July 16, 2025) - Delota Corp. (CSE: NIC) (FSE: S62) ("Delota" or the "Company"), a leading Canadian omni-channel retailer of nicotine vape and alternative tobacco products, announces that it has changed its auditor to Horizon Assurance LLP (the "Successor Auditor") effective July 15, 2025. The Company's predecessor auditor, Stern & Lovrics LLP (the "Predecessor Auditor") resigned effective July 15, 2025, at the Company's request. The Successor Auditor's appointment has b ...

Turning Point Brands (TPB) shares soared 5.1% in the last trading session to close at $78.39. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 1.4% loss over the past four weeks.Turning Point Brands shares are gaining on optimism surrounding growth in the modern oral segment, supported by expanding nicotine pouch sales and increasing market penetration. The company’s focus on brand building, retail partnerships, and operational en ...